
Featured Article
13 min read
Foundayo Approved: What to Know About Lilly's Oral GLP-1 Pill in 2026
Foundayo (orforglipron) is now FDA approved as Lilly's once-daily oral GLP-1 for chronic weight management. See what approval means, how it compares with oral Wegovy and tirzepatide, and what patients should do next.











































